Simultaneous Photoautotrophic Production of DHA and EPA by Tisochrysis Lutea and Microchloropsis Salina in Co-culture
Overview
Affiliations
Marine microalgae have received much attention as a sustainable source of the two health beneficial omega-3-fatty acids docosahexaenoic acid (DHA, C22:6) and eicosapentaenoic acid (EPA, C20:5). However, photoautotrophic monocultures of microalgae can only produce either DHA or EPA enriched biomass. An alternative may be the photoautotrophic co-cultivation of Tisochrysis lutea as DHA-producer with Microchloropsis salina for simultaneous EPA production to obtain EPA- and DHA-rich microalgae biomass in a nutritionally balanced ratio. Photoautotrophic co-cultivation processes of T. lutea and M. salina were studied, applying scalable and fully controlled lab-scale gas-lift flat-plate photobioreactors with LED illumination for dynamic climate simulation of a repeated sunny summer day in Australia [day-night cycles of incident light (PAR) and temperature]. Monocultures of both marine microalgae were used as reference batch processes. Differences in the autofluorescence of both microalgae enabled the individual measurement, of cell distributions in co-culture, by flow cytometry. The co-cultivation of T. lutea and M. salina in artificial sea water with an inoculation ratio of 1:3 resulted in a balanced biomass production of both microalgae simultaneously with a DHA:EPA ratio of almost 1:1 (26 mg g, and 23 mg g, respectively) at harvest after depletion of the initially added fertilizer. Surprisingly, more microalgae biomass was produced within 8 days in co-cultivation with an increase in the cell dry weight (CDW) concentration by 31%, compared to the monocultures with the same amount of light and fertilizer. What is more, DHA-content of the microalgae biomass was enhanced by 33% in the co-culture, whereas EPA-content remained unchanged compared to the monocultures.
Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation.
Cutolo E, Campitiello R, Di Dato V, Orefice I, Angstenberger M, Cutolo M Mar Drugs. 2025; 23(2).
PMID: 39997210 PMC: 11857744. DOI: 10.3390/md23020086.
Literakova P, Zavrel T, Buzova D, Kastanek P, Cerveny J Front Nutr. 2024; 11:1290701.
PMID: 38854161 PMC: 11157098. DOI: 10.3389/fnut.2024.1290701.
Monitoring Changes to Alkenone Biosynthesis in Commercial Microalgae.
ONeil G, Keller A, Balila J, Golden S, Sipila N, Stone B ACS Omega. 2024; 9(14):16374-16383.
PMID: 38617607 PMC: 11007839. DOI: 10.1021/acsomega.4c00087.